The worldwide dehydration monitoring systems market was valued at USD 348.7 million in 2018 and is anticipated to grow at a CAGR of 9.6% over the forecast period. The main factors driving the growth of dehydration monitoring systems market are people's changing focus to smart fitness and intelligent health decisions, accessibility of economical and enhanced types of dehydration monitoring solutions, and the accessibility of the multiple technologies. Another reason that triggers market development is the increase in consumer demand for the non-invasive techniques for dehydration monitoring. Other factors contributing to market growth are growing geriatric population and the advanced usage of dehydration monitoring systems in the diagnosis of multiple illnesses.
The market for dehydration monitoring systems was estimated to be worth US$ 535.6 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 7.3% from 2023 to US$ 1,083.1 million by 2033.
Dehydration affects human physiology in many ways. Dehydration concentrations of as little as 2% body weight are noted to cause significant decrease in physical performance. Also, mild dehydration may lead to compromised cognitive functions including short-term memory loss, lack of concentration, and motor abilities. It is also recognized empirically that water shortage can boost irritability and headaches.
Long-term impacts of dehydration on gastrointestinal, kidney, and heart functions contribute to constipation, chronic kidney disease, and heart illness respectively. These symptoms can, in conjunction, lead to significant degradation of health, as well as a loss of productivity in the workplace or at school/college. While estimating the precise contribution of dehydration to occupational health risks is almost impossible, the overall financial burden of occupational injury and disease in the United States in 2010 was estimated at about USD 280 billion.
Many designs have been developed for veterinary wearable devices to provide real-time information about the possible alarming changes in the body, including monitoring of hydration. Dehydration sensors, for instance created by the University of California's Javey group, Berkeley uses electrochemical sensors to assess the user's perspiration content. Colorimetric sensors and optical image analysis of captured sweat samples are used by another device by Koh et al. to quantitate water loss.
Other hydration biomarkers for clinical evaluation include osmolality of urine, specific gravity of urine, mucus wetness and tear production. Most of these techniques are not appropriate for adaptation to non-clinical, private consumer-grade devices; hence there is growing need for a non-invasive, real-time, hydration sensor systems.
Dehydration Monitoring Systems Market Scope
Metrics | Details |
Base Year | 2023 |
Historic Data | 2018-2022 |
Forecast Period | 2024-2032 |
Study Period | 2018-2033 |
Forecast Unit | Value (USD) |
Revenue forecast in 2033 | US$ 1,083.1 million |
Growth Rate | CAGR of 7.3 % during 2023-2033 |
Segment Covered | Product Type, Application, Distribution Channel, Regions |
Regions Covered | North America, Europe, Asia Pacific, South America, Middle East and Africa |
Key Players Profiled | Abbott Laboratories, Aerotel Medical Systems, AMD Global Telemedicine, Baxter International Inc., Boston Scientific Corporation, GE Healthcare, Masimo Corporation, Medtronic PLC, F. Hoffmann-La Roche AG, Omron Corporation |
Key segments of the global dehydration monitoring systems market
Product Overview, (USD Million)
- Mobile Devices
- Wireless Chemical Sensors
- Biomedical Sensors
- Optical Sensors
- Wearable Devices
- Wristbands
- Adhesive Patches
- Head Bands
Application Overview, (USD Million)
- Disease Diagnosis
- Drug Abuse Detection
- Athletic Performance Optimization
Regional Overview, (USD Million)
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Benelux
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South East Asia
- Australia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of South America
- Middle East & Africa
- GCC
- Rest of MEA
Frequently Asked Questions (FAQ) :
Mobile technology has become an omnipresent component of everyday life and is altering the way clinical care is provided and clinical research is carried out. For self-care as well as sharing with health care suppliers, we have unprecedented access to information. A multidisciplinary team of scientists, clinicians, information technologists, software developers, and statisticians are required to meet the challenge presented by the influx of wearable device data. While the possibility of what can be achieved with the evolving wearable technologies appears to be unlimited, various regulatory agencies have provided a framework for setting standards for clinical applications.
Mobile health technology continues to create promise for oncology care and research with growing accessibility and sophistication. Mobile health, or mHealth, technology includes equipment that allow wireless communication or information transmission. More lately, wearable phones and sensors have significantly improved business availability and consumer acceptance, with the capacity to communicate wirelessly for data transmission and storage. Wearable health devices allow long-term private health monitoring. These include monitoring of physical exercise as well as outpatient monitoring of medically appropriate information such as essential signs and electrocardiography.
Wearable and mobile technology can provide cost-effective and scalable possibilities to monitor patients remotely and often in real-time during critical cancer care phases. By using this technology, healthcare providers have access to both objective and patient-reported health information to facilitate clinical choices that can lead to better compliance, quality of life, and better therapy results. Furthermore, implementing wearable and mobile technology applications in clinical trials may standardize information collection procedures and capture more accurate and frequent information for better study results.
Wearable monitoring devices are increasingly helping individuals better track their health status for self-health monitoring at both an activity/fitness level and at medical level, offering more information for clinicians with opportunities for previous diagnosis and therapy advice. The technology revolution in electronic device miniaturization enables more reliable and adaptable wearables to be designed, contributing to a global shift in the strategy to health monitoring systems. These devices are an evolving technology that allows constant outpatient surveillance of human essential signs during daily life (during job, at home, during sports, etc.) or in a clinical setting, with the benefit of minimizing pain and interference with ordinary human operations.
Also these devices have become an essential component of private health systems, a concept launched in the early 1990s to put individual citizens at the core of health care delivery, manage their own health and interact with care providers— a notion frequently referred to as 'patient empowerment’. The goal was to raise people's interest in their health status, improve the quality of care and make use of the new capabilities of technology.
These devices generate a synergy between various scientific fields such as biomedical technology, micro and nanotechnology, material engineering, electronic engineering, and ICT. This characteristic enables essential information to be acquired during various daily operations, ensuring better medical diagnostic assistance and/or helping to recover from medical intervention or body injury better and quicker. Also, these are very helpful in sport / fitness activities to monitor the performance of athletes, monitor body reaction of military people in various dangerous circumstances and to better handle their work and occupational health.
According to Adroit Market Research, the wearable devices market is the fastest growing market, growing with the CAGR of 11.8% over the forecast period, and is anticipated to reach almost USD 368.0 billion in 2025.
As per the World Health Organization, 80% of cases of dehydration can be handled with oral rehydration solution (ORS), however in the United States only about 20% of cases of dehydration are treated with ORS. The U.S. spends far more on healthcare than any other nation, but the results for these expenses do not appear to be better and there is no universal access. The U.S. spends more on healthcare than cumulating the next top 10 nations. A look at different statistics demonstrates that the U.S. is nowhere close to the top health measures of the World Health Organization (WHO) in categories such as infant mortality or life expectancy. Dehydration is a significant problem in underdeveloped countries causing fatalities in millions of children every year. However, there is the misconception that dehydration could be a health hazard only in developing nations. Unfortunately, a few hundred kids in the U.S. too die of dehydration unnecessarily every year. Up to 75% of the U.S. population is projected to be chronically dehydrated.
Dehydration can be prevented, treated and reversed easily. Dehydration is a significant but often ignored issue in the U.S., with billions of dollars being spent unnecessarily each year on associated medical expenses. Hospitalizations due to dehydration are preventable and deemed an outpatient-sensitive disease because they can possibly be prevented with prompt, efficient outpatient or home care. The most vulnerable to dehydration are children and the elderly.
The second most prevalent cause of admissions is pediatric dehydration / gastroenteritis, which accounts for 15% of all children's hospitalizations. Dehydration is the most prevalent issue in elderly with fluids and electrolytes imbalance. Also, dehydration is listed as a side effect in almost half of the top 25 most prescribed medicines in the U.S.